← Insider buys
REPL

Replimune Group, Inc. · Healthcare

Chief Commercial Officer Christopher Sarchi sold $57K of Replimune Group, Inc.

Sold$57,385
$10.92Price
5,255Shares
−7%Stake

What REPL did after the filing

Prices for REPL after this filing aren't in yet.

Traded Thu, Nov 16. Filed Fri, Nov 17, 8:00 PM ET, after the close. Not investment advice.